Wael Muselmani | Senior Investment Manager
MedCity

Wael is a member of the Life Sciences Cluster Development team at MedCity, the team supports the development of new life sciences infrastructure to attract more inward investment and research into London region. He guides life sciences organisations to find right R&D and manufacturing spaces in London and works with developers, investors and local government to facilitate development of new life sciences spaces and city’s innovation districts. Wael’s experience includes academic research, pharmaceutical sales and marketing, product management, business development and investment roles.

Appearances:

Day 1: 14th May @ 13:45

Panel: Demand vs supply-how can we keep up with UK’s ever-growing need for lab space?

How can we innovate with limited space? (e.g high-rise labs, repurposing old buildings, and creative space optimization)
What new lab developments are emerging in London?
How are hubs outside of London evolving to meet demand?
What are companies/institutes seeking in lab spaces and how can these be achieved?
How can technology drive efficiency and flexibility in lab design? (e.g. modular setups, smart building technology, and adaptable infrastructure.)

Josh Palmer, Global Head of Real Estate, GlaxoSmithKline